Ge healthcare receives fda clearance for portrait mobile, a first-of-its-kind, wireless monitoring solution aiding early detection of patient deterioration

Chicago--(business wire)--ge healthcare (nasdaq: gehc) today announced it has received 510(k) clearance from the united states food and drug administration (fda) for its portrait mobile wireless and wearable monitoring solution. the portrait mobile platform enables real-time continuous monitoring with a personalized view of the patient's vitals while keeping patients mobile during critical recovery periods, especially after surgery or discharge from the intensive care unit. continuously monitor.
GEHC Ratings Summary
GEHC Quant Ranking